Zhou Y, Liu D, Hou P, Zha KJ, Wang F, Zhou K, He W, Gao JB. Low-dose spectral insufflation computed tomography protocol preoperatively optimized for T stage esophageal cancer - preliminary research experience. World J Gastroenterol 2018; 24(36): 4197-4207 [PMID: 30271084 DOI: 10.3748/wjg.v24.i36.4197]
Corresponding Author of This Article
Jian-Bo Gao, MD, PhD, Professor, Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou 450052, Henan Province, China. cjr_gaojianbo@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Prospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Sep 28, 2018; 24(36): 4197-4207 Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4197
Table 1 Basic clinical characteristics of patients n (%)
Variable
Group A (n = 45)
Group B (n = 40)
Group C (n = 35)
Gender
Male
25 (56)
19 (48)
22 (64)
Female
50 (44)
21 (52)
13 (36)
Age (yr)
Medium
67
61
63
Range
55-82
52-79
50-81
Location
Upper esophagus
11 (24)
8 (20)
6 (16)
Middle esophagus
14 (32)
11 (28)
11 (32)
Lower esophagus
20 (44)
22 (56)
18 (52)
Differentiation degree
High
17 (38)
9 (23)
10 (28)
Medium
23 (50)
25 (62)
14 (40)
Low
5 (12)
6 (15)
11 (32)
Symptom
Progressive dysphagia
18 (40)
19 (48)
21 (60)
Vomiting
13 (28)
8 (20)
4 (12)
Intermittent sternal sensation
9 (20)
8 (20)
6 (16)
Hematemesis and sense of frustration
5 (12)
5 (12)
4 (12)
Table 2 Comparison between esophageal squamous cell carcinoma-enhanced features and pathological T stage
Group
Enhancement feature
Medullary type
Ulcerative type
Mushroom type
Total
T1/2
T3
T1/2
T3
T1/2
T3
A
Layered
3
2
2
0
1
0
8
Unlayered
6
8
6
4
4
3
31
Total
9
10
8
4
5
3
39
B
Layered
5
2
0
0
0
0
7
Unlayered
4
8
2
5
4
3
26
Total
9
10
2
5
4
3
33
C
Layered
6
1
1
1
3
0
12
Unlayered
2
8
2
4
2
2
20
Total
8
9
3
5
5
2
22
Table 3 Comparisons between morphological changes of the triangular area in front of the vertebral body and pathological T stage
Group
Morphological change of triangle area in front of vertebral body
Medullary type
Ulcerative type
Mushroom type
Total
T3
T4
T3
T4
T3
T4
A
Clear
6
3
3
0
3
0
15
Blurred or disappeared
4
3
1
0
0
0
8
Total
10
6
4
0
3
0
23
B
Clear
7
3
5
0
3
0
18
Blurred or disappeared
3
4
0
0
0
0
7
Total
10
7
5
0
3
0
25
C
Clear
7
6
5
0
2
0
20
Blurred or disappeared
2
7
0
0
0
0
9
Total
9
13
5
0
2
0
29
Table 4 Comparison of pathological T stage and combined diagnosis of the triangular area in front of the vertebral body
Group
T stage
Medullary type
Ulcerative type
Mushroom type
Total
T3
T4
T3
T4
T3
T4
A
T3
6
1
3
0
3
0
13
T4
4
5
1
0
0
0
10
Total
10
6
4
0
3
0
23
B
T3
8
1
5
0
3
0
17
T4
2
6
0
0
0
0
8
Total
10
7
5
0
3
0
25
C
T3
6
2
5
0
2
0
15
T4
3
11
0
0
0
0
14
Total
9
13
5
0
2
0
29
Table 5 Accuracy of T stage comparisons between groups
Stage
Group
n
TP
TN
FP
FN
Sensitivity (%)
Specificity (%)
Accuracy (%)
PPV (%)
NPV (%)
A
45
7
9
15
14
31.82
60.87
46.67
43.75
48.28
T1/2
B
40
5
9
10
16
33.33
64.00
52.50
35.71
61.54
C
35
7
7
9
12
43.75
63.16
54.29
50.00
57.14
A
45
7
9
10
19
41.17
67.86
57.78
43.75
65.52
T3
B
40
8
8
10
14
44.44
63.64
55.00
50.00
58.33
C
35
9
5
7
14
56.25
73.68
65.71
60.00
66.67
A
45
5
12
1
27
83.33
69.23
71.11
29.41
96.43
T4
B
40
6
10
1
23
85.71
69.70
72.50
37.50
95.83
C
35
11
7
2
15
84.62
68.18
74.29
61.11
94.12
Citation: Zhou Y, Liu D, Hou P, Zha KJ, Wang F, Zhou K, He W, Gao JB. Low-dose spectral insufflation computed tomography protocol preoperatively optimized for T stage esophageal cancer - preliminary research experience. World J Gastroenterol 2018; 24(36): 4197-4207